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Lausanne, 2) Department of Ambulatory Care and Community Medicine,
Lausanne, 3) Swiss Reference Centre for Emerging Viral Diseases, Laboratory
of Virology, University Hospital of Geneva and 4) Infectious Diseases Service,
University Hospital of Geneva, Geneva, SwitzerlandAbstractZika virus is an emerging ﬂavivirus that is following the path of
dengue and chikungunya. The three Aedes-borne viruses cause
simultaneous outbreaks with similar clinical manifestations which
represents a diagnostic challenge in ill returning travellers. We
report the ﬁrst Zika virus infection case imported to Switzerland
and present a diagnostic algorithm.
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E-mail: noemie.boillat@chuv.chOn 19 November 2015 a 29-year-old woman attended our
clinic with a 4-day ﬂulike syndrome after a trip in Colombia
from 30 October to 15 November. During her trip home, she
developed a feverish feeling with diarrhoea; 24 hours later, shew Microbe and New Infect 2016; 11: 6–7
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p://dx.doi.org/10.1016/j.nmni.2016.02.003noted a pruritic rash on her trunk. Over the coming days, she
presented retro-orbital headache and arthralgia involving her
wrists and interphalangeal joints. Physical examination revealed
a maculopapular rash on her trunk and limbs. Full blood count
was normal. Because of her stay in a region with concurrent
arbovirus epidemics, as well as clinical presentation and incu-
bation time, the differential diagnosis included dengue, chi-
kungunya and Zika virus infection. Given the absence of
concerning clinical signs, the patient received symptomatic
treatment and was followed up as an outpatient. Blood smear,
malaria (SD Bioline Malaria Ag P.f/Pan) and dengue rapid tests
(SD Bioline Dengue Duo IgG/IgM/NS1Ag) were negative. On
serum collected on 20 November (5 days after onset of
symptoms), chikungunya IgM/IgG (immunoﬂuorescence com-
mercial test chikungunya (Euroimmun, Germany)) was negative,
but real-time Zika reverse transcription (RT) PCR was positive
(38 Ct; method developed by National Reference Center for
Arboviruses, Service de Santé des Armées, Marseille, France).
Urine collected 12 days after symptom onset was positive for
Zika by real-time RT-PCR with a higher virus load than in
serum collected 7 days before (34 Ct). At the last medical visit,
20 days after symptom onset, she described progressive relief
from the arthralgia, and urine real-time RT-PCR was negative.
This was the ﬁrst imported case of Zika infection in
Switzerland.
Clinical manifestations of Zika infection are similar to
dengue and chikungunya (fever, exanthema, conjunctivitis,
retro-orbital headache and arthralgia) [1]. Identiﬁcation of the
virus has speciﬁc management implications for clinicians. In the
case of dengue, a close follow-up for thrombocytes and hae-
matocrit should be done. In the case of chikungunya, the high
prevalence of chronic arthralgia should be discussed. In the
presence of Zika, potential sexual and maternal-foetal trans-
mission (with risk of congenital microcephaly) should be
presented [2].
A reliable immunochromatographic rapid diagnostic test
makes dengue infection easy to rule out in acutely ill travellers
[3]. NS1 antigen is highly speciﬁc but in the presence of dengue
IgM only, cross-reactivity between the two ﬂaviviruses—
dengue and Zika—has been described [4]. Chikungunya can be
detected by PCR in blood, and serology by immunoﬂuores-
cence is expected to be positive after 5 days of symptoms.
Cross-reactivity between ﬂaviviruses limits the use of serology
for Zika diagnosis, which relies on virus RNA detection by PCR
in blood, preferably fewer than 5 days after symptom onset
(short viraemic period 3–5 days). As illustrated in our case,
virus RNA in urine persists for longer periods (15–20 days) and
can be useful to conﬁrm infection [5]. Virus can also be
detected in saliva during the viraemic period [6]. To supportEuropean Society of Clinical Microbiology and Infectious Diseases
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FIG. 1. Diagnostic algorithm for travellers with nonspeciﬁc febrile illness returning from regions experiencing simultaneous outbreaks of dengue,
chikungunya and Zika virus infections. RDT, rapid diagnostic test.
NMNI Letter to the Editor 7clinicians in their diagnostic workup, we present in Fig. 1 a
diagnostic algorithm for travellers with nonspeciﬁc febrile
illness returning from regions experiencing simultaneous out-
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